secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2023-09-14T23:59:59+00:00
Accession:  0001193125-23-235298
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cue Biopharma director Aaron Fletcher resigns from board effective Oct 9, 2023
------------------------------------------------------------------------------

- Aaron Fletcher notified Cue Biopharma of resignation from Board and all committees.
- Resignation effective October 9, 2023, is not due to any disagreement with the Company.
- No replacement or successor named; board size adjusted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000119312523235298/0001193125-23-235298-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000119312523235298/d540189d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-235298

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer